PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $236,000 | -82.9% | 100,000 | -28.0% | 0.00% | -82.4% |
| Q3 2021 | $1,383,000 | -69.2% | 138,807 | -59.0% | 0.02% | -67.3% |
| Q2 2021 | $4,486,000 | -24.2% | 338,807 | 0.0% | 0.05% | -31.6% |
| Q1 2021 | $5,922,000 | -19.6% | 338,807 | +17.7% | 0.08% | -26.9% |
| Q4 2020 | $7,362,000 | +93.5% | 287,896 | -0.8% | 0.10% | +79.3% |
| Q3 2020 | $3,805,000 | -52.0% | 290,199 | 0.0% | 0.06% | -51.7% |
| Q2 2020 | $7,931,000 | +23.4% | 290,199 | -28.9% | 0.12% | -6.2% |
| Q1 2020 | $6,429,000 | – | 408,161 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |